Disseminated peritoneal leiomyomatosis responds to systemic chemotherapy
Journal
Oncology
Journal Volume
76
Journal Issue
1
Pages
55-58
Date Issued
2008
Author(s)
Abstract
Leiomyomatosis peritonealis disseminata (LPD) is a rare disease entity characterized by multiple peritoneal tumors composed of benign but proliferative smooth muscle cells. Surgery is the mainstay treatment for LPD. We present a 50-year-old woman who had previously undergone several surgical resections including bilateral oophorectomy for recurrent LPD. Because of progressive tumors in the peritoneum and metastatic tumors in the liver and lungs, systemic chemotherapy with doxorubicin and dacarbazine was prescribed. Objective tumor response was achieved and sustained for 1 year. This case presentation suggests that systemic chemotherapy may be considered as a treatment option for LPD patients developing unresectable or metastatic disease. Copyright ? 2008 S. Karger AG.
SDGs
Other Subjects
dacarbazine; docetaxel; doxorubicin; estrogen receptor; etoposide; gemcitabine; ifosfamide; progesterone receptor; stem cell factor receptor; adult; article; cancer chemotherapy; cancer diagnosis; cancer growth; cancer recurrence; case report; continuous infusion; cytoreductive surgery; female; histopathology; human; human tissue; hysterectomy; immunohistochemistry; leiomyomatosis; leiomyomatosis peritonealis disseminata; liver metastasis; lung metastasis; multiple cycle treatment; nuclear magnetic resonance imaging; ovariectomy; pathogenesis; priority journal; Female; Humans; Leiomyomatosis; Middle Aged; Mitosis; Neoplasm Recurrence, Local; Peritoneal Neoplasms; Uterine Neoplasms
Type
journal article